1. Home
  2. WHD vs BLLN Comparison

WHD vs BLLN Comparison

Compare WHD & BLLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cactus Inc.

WHD

Cactus Inc.

HOLD

Current Price

$52.58

Market Cap

3.7B

Sector

Industrials

ML Signal

HOLD

BLLN

BillionToOne Inc.

N/A

Current Price

$79.45

Market Cap

3.7B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
WHD
BLLN
Founded
2011
2016
Country
United States
United States
Employees
N/A
713
Industry
Metal Fabrications
Medical Specialities
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
3.7B
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
WHD
BLLN
Price
$52.58
$79.45
Analyst Decision
Buy
Buy
Analyst Count
6
7
Target Price
$56.33
$126.71
AVG Volume (30 Days)
884.8K
317.9K
Earning Date
05-06-2026
05-06-2026
Dividend Yield
1.04%
N/A
EPS Growth
18.99
N/A
EPS
0.19
N/A
Revenue
$1,079,051,000.00
N/A
Revenue This Year
$44.76
$45.96
Revenue Next Year
$5.51
$30.11
P/E Ratio
$282.57
N/A
Revenue Growth
N/A
N/A
52 Week Low
$33.30
$61.96
52 Week High
$59.25
$138.70

Technical Indicators

Market Signals
Indicator
WHD
BLLN
Relative Strength Index (RSI) 56.90 50.53
Support Level $43.91 $64.99
Resistance Level $59.02 $83.20
Average True Range (ATR) 1.85 6.88
MACD 0.55 -0.07
Stochastic Oscillator 76.51 46.34

Price Performance

Historical Comparison
WHD
BLLN

About WHD Cactus Inc.

Cactus Inc is engaged in the designing, manufacturing, and sale of wellheads and pressure control equipment. Its principal products include Cactus SafeDrill wellhead systems, conventional wellheads, and production valves among others. The company also provides mission-critical field services, including service crews to assist with the installation, maintenance, and safe handling of the wellhead and pressure control equipment, as well as repair services for equipment that it sells or rents. It sells or rents its products principally for onshore unconventional oil and gas wells that are utilized during the drilling, completion (including fracturing), and production. It has two operating segments; Pressure Control, which generates key revenue and Spoolable Technologies.

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

Share on Social Networks: